Mr. Kim D. Blickenstaff

• 
  www.sec.gov/Archives/edgar/data/1093557/0001005477-06-0 - [Cached Version]
  Published on: 5/15/2006    Last Visited: 5/18/2006  

  0001238913 BLICKENSTAFF KIM D C/O DEXCOM, INC. 5555 OBERLIN DRIVE SAN DIEGO CA 92121 1 0 0 0

• 
  www.crmz.com/Report/ReportPreview.asp?BusinessId=533773 - [Cached Version]
  Published on: 6/15/2008    Last Visited: 6/15/2008  

  Kim D. Blickenstaff
  Chairman of the Board
  Medivation, Inc.

• 
  www.sec.gov/Archives/edgar/data/1097136/0001193125-08-0 - [Cached Version]
  Published on: 4/29/2008    Last Visited: 8/10/2008  

  Kim D. Blickenstaff(2)
  ...
  Kim D. Blickenstaff.Mr. Blickenstaff has served on our Board since March 2002.Since September 2007, Mr. Blickenstaff has served as the Chief Executive Officer and as a member of the board of directors of Tandem Diabetes Care, a privately-held medical device company.Mr. Blickenstaff currently serves as chairman of the board of directors of Medivation, a publicly-traded drug development company.From April 1988 until its acquisition in June 2007, Mr. Blickenstaff served as Chief Executive Officer and as a member of the board of directors of Biosite Incorporated, a publicly-traded manufacturer of medical diagnostic products.From 2001 to September 2007, Mr. Blickenstaff served as a member of the board of directors of DexCom, a publicly-traded developer of glucose monitoring devices.Prior to 1998, Mr. Blickenstaff held various positions in finance, operations, research management, sales management, strategic planning, and marketing with Baxter, National Health Laboratories and Hybritech.Mr. Blickenstaff earned his B.A. in Political Science at Loyola University, Chicago and his M.B.A. at the Graduate School of Business, Loyola University, Chicago.

• 
  www.sec.gov/Archives/edgar/data/1011835/0001193125-08-0 - [Cached Version]
  Published on: 4/29/2008    Last Visited: 8/10/2008  

  Kim D. Blickenstaff
  ...
  Kim D. Blickenstaff.Mr. Blickenstaff has served as a member of our Board of Directors since 2005 and as the Chairman of our Board of Directors since 2007.Mr. Blickenstaff is a member of our Audit Committee, our Compensation Committee and our Nominating and Corporate Governance Committee.Mr. Blickenstaff has been President and Chief Executive Officer of Tandem Diabetes Care, a privately held company focusing on improved insulin infusion therapy, since September 2007.From 1988 until August 2007, Mr. Blickenstaff served as Chairman and Chief Executive Officer of Biosite Incorporated, a provider of medical diagnostic products.Mr. Blickenstaff is also a director of SenoRx, Inc., a developer of improved breast cancer biopsy and treatment devices, and is a member of their compensation committee.Mr. Blickenstaff was formerly a certified public accountant and has more than ten years of experience overseeing the preparation of financial statements.Mr. Blickenstaff received a B.A. from Loyola University, Chicago and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.
  ...
  The Board of Directors has determined that each of the following directors is an "independent director" as such term is defined in NASDAQ Marketplace Rule 4200(a)(15): Daniel Adams, Gregory Bailey, Kim Blickenstaff and W. Anthony Vernon.

• 
  www.sec.gov/Archives/edgar/data/1097136/0001181431-08-0 - [Cached Version]
  Published on: 6/9/2008    Last Visited: 6/10/2008  

  0001238913 BLICKENSTAFF KIM D C/O SENORX, INC. 11 COLUMBIA, SUITE A ALISO VIEJO CA 92656 1 0 0 0

• 
  www.sec.gov/Archives/edgar/data/1011835/0001193125-07-0 - [Cached Version]
  Published on: 4/24/2007    Last Visited: 4/25/2007  

  Kim D. Blickenstaff
  ...
  Kim D. Blickenstaff.Mr. Blickenstaff has served as a member of our Board of Directors since 2005 and as the Chairman of our Board of Directors since 2007.Mr. Blickenstaff is a member of our Audit Committee, our Compensation Committee and our Nominating and Corporate Governance Committee.Mr. Blickenstaff has been the Chairman and Chief Executive Officer and a director of Biosite Incorporated, a provider of medical diagnostics, since April 1988.Mr. Blickenstaff is a director and member of the audit committee of DexCom, Inc., a medical technology company, and is also a director of several privately held medical products companies.Mr. Blickenstaff was formerly a certified public accountant and has more than ten years of experience overseeing the preparation of financial statements.Mr. Blickenstaff received a B.A. from Loyola Marymount College and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.
  ...
  The Board of Directors has determined that each of the following directors is an "independent director" as such term is defined in Marketplace Rule 4200(a)(15) of the National Association of Securities Dealers, or NASD: Daniel Adams, Kim Blickenstaff and W. Anthony Vernon.
  ...
  The Board of Directors has further determined that Mr. Blickenstaff is an "audit committee financial expert," as such term is defined in Item 407(d) of Regulation S-B promulgated by the SEC, by virtue of his relevant experience listed in his biographical summary provided above in the section entitled "Proposal 1,Election of Directors."
  
  Audit Committee.
  ...
  The Compensation Committee is comprised of Directors Adams, Blickenstaff and Vernon (Chair).
  ...
  The Nominating and Corporate Governance Committee is comprised of Directors Adams (Chair), Blickenstaff and Vernon.

• 
  www.sec.gov/Archives/edgar/data/834306/0001193125-07-08 - [Cached Version]
  Published on: 4/13/2007    Last Visited: 4/20/2007  

  Kim D. Blickenstaff*
  ...
  Kim D. Blickenstaff is a founder of Biosite and has served as Chief Executive Officer and a director of the Company since April 1988 and was Secretary from April 1988 to June 2002.From April 1988 to October 2004, Mr. Blickenstaff also served as President of the Company.In October 2004 he was appointed Chairman of the Board of Directors.Before forming the Company, he held various positions in finance, operations, research management, sales management, strategic planning, and marketing with Baxter Travenol, National Health Laboratories and Hybritech Incorporated.Mr. Blickenstaff is also a director of Medivation, Inc., DexCom, Inc. and SenoRx, Inc. and two privately held medical product companies.Mr. Blickenstaff received a B.A. from Loyola University, Chicago and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.

• 
  www.sec.gov/Archives/edgar/data/1011835/0001181431-08-0 - [Cached Version]
  Published on: 9/11/2008    Last Visited: 9/12/2008  

  0001238913 BLICKENSTAFF KIM D C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 1 0 0 0

• 
  www.sec.gov/Archives/edgar/data/1238913/0001181431-07-0 - [Cached Version]
  Published on: 6/15/2007    Last Visited: 7/21/2007  

  0001238913 BLICKENSTAFF KIM D C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 92105 1 0 0 0

• 
  www.sec.gov/Archives/edgar/data/834306/0001104659-06-02 - [Cached Version]
  Published on: 4/28/2006    Last Visited: 4/30/2006  

  Kim D. Blickenstaff
  ...
  Mr. Blickenstaff, a founder of Biosite, has served as Chief Executive Officer and a director of the Company since April 1988 and was Secretary from April 1988 to June 2002.From April 1988 to October 2004, Mr. Blickenstaff also served as President of the Company.In October 2004 he was appointed Chairman of the Board of Directors.Before forming the Company, he held various positions in finance, operations, research management, sales management, strategic planning, and marketing with Baxter Travenol, National Health Laboratories and Hybritech Incorporated.Mr. Blickenstaff is also a director of Medivation, Inc. and DexCom, Inc. and several privately held medical product companies.Mr. Blickenstaff received a B.A. from Loyola University, Chicago and an M.B.A. from the Graduate School of Business, Loyola University, Chicago.
  ...
  Kim D. Blickenstaff *

Page:  1 2 3 4 5